Is de novo hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt increased?

A Hüsing-KabarT MeisterM KöhlerW DomschkeI KabarC WilmsB HildH H SchmidtHauke Sebastian Heinzow

Published in: United European gastroenterology journal (2017)

In patients with end-stage liver disease, transjugular intrahepatic portosystemic shunt insertion is significantly associated with reduced rates of hepatocellular cancer development.

Keyphrases

pulmonary artery
papillary thyroid
squamous cell
pulmonary hypertension
lymph node metastasis
pulmonary arterial hypertension
squamous cell carcinoma
childhood cancer